approval
saveAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
community read0 votes
Sponsor: MANNKIND. Form: POWDER. Route: INHALATION
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalJan 23, 2026 · 301d ago
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalFeb 3, 2023 · 1386d ago
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalOct 25, 2018 · 2948d ago
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalApr 24, 2018 · 3132d ago
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalSep 29, 2017 · 3339d ago
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalApr 7, 2016 · 3879d ago
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalFeb 17, 2016 · 3929d ago
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalSep 16, 2015 · 4083d ago
comments(0)
5-min edit window · permanent after that